2. Academic Validation
  3. Low-dose IL-2 Ameliorates Experimental Autoimmune Myasthenia Gravis in Rats by Restoring the CD4-positive Helper T-cell Balance Via the JAK/STAT5 Pathway

Low-dose IL-2 Ameliorates Experimental Autoimmune Myasthenia Gravis in Rats by Restoring the CD4-positive Helper T-cell Balance Via the JAK/STAT5 Pathway

  • J Neuroimmune Pharmacol. 2026 Jan 31;21(1):9. doi: 10.1007/s11481-025-10276-5.
Shanshan Peng 1,  Xiaotong Kong 1,  Wenqi Tian 1,  Fanfan Xu 1,  Hanlu Cai 1,  Fei Wu 1,  Ying Li 1,  Guanghao Xin 1,  Jingyan Niu 1,  Yingjie Ren 1,  Lei Li 1,  Jianjian Wang 1,  Huixue Zhang 2,  Lihua Wang 3
Affiliations

Affiliations

  • 1 Department of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150081, China.
  • 2 Department of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150081, China. [email protected].
  • 3 The Second Affiliated Hospital of Harbin Medical University, Harbin, 150081, China. [email protected].
PMID: 41619069 DOI: 10.1007/s11481-025-10276-5
Keywords

CD4-positive helper t cell; Experimental autoimmune myasthenia gravis; Low-dose IL-2; Myasthenia gravis; Tfh; Tfr; Th17; Treg.

Figures
Products
Inhibitors & Agonists
Other Products